its impact on macrophage function in aging Cynthia H. Canan,1 Nandan S. Gokhale,1,2 Bridget Carruthers,3 William P. Lafuse, Larry S. Schlesinger, Jordi B. Torrelles, and Joanne Turner4 Department of Microbial Infection and Immunity, College of Medicine, and Center for Microbial Interface Biology, The Ohio State University, Columbus Ohio, USA RECEIVED FEBRUARY 13, 2014; REVISED MAY 28, 2014; ACCEPTED JUNE 1, 2014. DOI: 10.1189/jlb.4A0214-093RR
ABSTRACT chronic pulmonary disorders, such as emphysema, bronchitis,
Systemic inflammation that occurs with increasing age and COPD [1– 4]. This systemic increase in basal inflammatory (inflammaging) is thought to contribute to the increased cytokines in old age has been termed inflammaging and is susceptibility of the elderly to several disease states. broadly attributed to altered immune cell function, particu- The elderly are at significant risk for developing pulmo- larly within the myeloid lineage [5]. However, studies of nary disorders and infectious diseases, but the contri- monocyte or macrophage function in vitro have been contra- bution of inflammation in the pulmonary environment dictory with some studies showing that the capacity of myeloid has received little attention. In this study, we demon- cells to produce inflammatory cytokines can be impaired in strate that the lungs of old mice have elevated levels of proinflammatory cytokines and a resident population of old age [6, 7], whereas others have shown that inflammatory highly activated pulmonary macrophages that are re- cytokine secretion can be enhanced [8, 9]. These disparities fractory to further activation by IFN-␥. The impact of this have often been attributed to the source of monocytes or de- inflammatory state on macrophage function was deter- rived/resident macrophages, as well as the specific stimulus mined in vitro in response to infection with M.tb. Macro- that has been used [5]. phages from the lungs of old mice secreted more pro- Our own studies have focused on resident tissue-derived pul- inflammatory cytokines in response to M.tb infection monary macrophages and have shown previously that macro- than similar cells from young mice and also demon- phages from the lungs of old mice are capable of secreting strated enhanced M.tb uptake and P-L fusion. Sup- abundant TNF-␣ and IL-12 in response to in vitro or in vivo plementation of mouse chow with the NSAID ibupro- stimulus with the virulent pulmonary pathogen M.tb [10 –12]. fen led to a reversal of lung and macrophage inflam- M.tb is a significant global threat, accounting for ⬎9 million matory signatures. These data indicate that the pulmonary environment becomes inflammatory with cases and 1.4 million deaths from tuberculosis each year [13, increasing age and that this inflammatory environ- 14]. M.tb is also responsible for significant morbidity and mor- ment can be reversed with ibuprofen. J. Leukoc. Biol. tality in the elderly [15], and the aged mouse model has been 96: 473– 480; 2014. used extensively to understand innate and adaptive immune function in the context of this infectious disease [16 –18]. The accumulated knowledge of immune cell function in vitro and Introduction in vivo in response to M.tb in humans and animal models [19] Increasing age is associated with an abundance of circulating makes this an ideal and globally relevant model system to in- inflammatory cytokines that are considered to be a significant vestigate macrophage function in old age. contributing factor to the susceptibility of the elderly to nu- Here, we extend our studies on pulmonary macrophage merous disease states, including diabetes, heart disease, and function in old age to characterize further the functional state of macrophages ex vivo and in response to in vitro infection with M.tb. Our data demonstrate that resident pulmonary mac- rophages from old mice are phenotypically and functionally Abbreviations: 15d-PDJ2:⫽15-deoxy-delta 12,14-PG D2, APC⫽allophycocyanin, BSL3⫽biosafety level 3, CIITA⫽class II, MHC, trans- activator, CMIF⫽Campus Microscopy and Imaging Facility, COPD⫽chronic 1. These authors contributed equally. obstructive pulmonary disease, COX⫽cyclooxygenase, CT⫽cycle thresh- 2. Current address: Dept. of Molecular Genetics and Microbiology, Duke old, DPBS⫽Dulbecco’s PBS, GFP-M.tb⫽GFP expressing M.tb strain Erd- University, Durham, NC 27710, USA. man, IRF-1⫽IFN regulatory factor 1, IRGM-1⫽immunity-related GTPase 3. Current address: Office of Environmental Health and Safety, The Ohio family M member 1, LAMP-1⫽lysosomal-associated membrane protein 1, State University, Columbus, OH 43210, USA. M.tb⫽Mycobacterium tuberculosis, MOI⫽multiplicity of infection, 4. Correspondence: Dept. of Microbial Infection and Immunity, College of MR⫽mannose receptor, NSAID⫽nonsteroidal anti-inflammatory drug, Medicine, and Center for Microbial Interface Biology, The Ohio State OADC⫽oleic albumin dextrose catalase, P-L⫽phago-lysosomal, PGH2⫽PG University, 786 Biomedical Research Tower, 460 West 12th Ave., Colum- H2, qPCR⫽quantitative PCR, RU⫽relative unit(s) bus, OH 43210, USA. E-mail: joanne.turner@osumc.edu